Bio-Techne (TECH) Cash from Operations (2009 - 2026)
Bio-Techne's (TECH) quarterly Cash from Operations came in at 86661000.0 in Q1 2026, up 110.75% year-on-year from 41120000.0 in Q1 2025, and up 5.16% quarter-over-quarter from 82411000.0 in Q4 2025.
Bio-Techne (TECH) Cash from Operations (2009 - 2026) Analysis & Trends
Bio-Techne's Cash from Operations history runs 18 years deep, the most recent figure standing at 86661000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 110.75% year-over-year to 86661000.0 in Q1 2026; TTM through Mar 2026 was 294858000.0, a 11.33% increase from a year earlier, with the FY2025 full-year figure at 287556000.0, down 3.82% from the prior year.
- Cash from Operations improved to 86661000.0 in Q1 2026 per TECH's latest filing, from 82411000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 102717000.0 in Q2 2022 and bottomed at 27585000.0 in Q3 2025.
- The 5-year median for Cash from Operations is 75496000.0 (2024), against an average of 71378352.94.
- Across the five-year window, Cash from Operations sank 56.82% in 2025 and jumped 110.75% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 64384000.0 in 2022, then rose by 29.09% to 83116000.0 in 2023, then increased by 1.48% to 84346000.0 in 2024, then decreased by 2.29% to 82411000.0 in 2025, then gained by 5.16% to 86661000.0 in 2026.
- Per Business Quant, the three latest TECH Cash from Operations figures stand at 86661000.0 (Q1 2026), 82411000.0 (Q4 2025), and 27585000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 86.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.66 Mn |
| Mar 31, 2026 | 86.66 Mn |
| Dec 31, 2025 | 82.41 Mn |
| Dec 31, 2025 | 82.41 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Jun 30, 2025 | 98.20 Mn |
| Jun 30, 2025 | 98.20 Mn |
| Mar 31, 2025 | 41.12 Mn |
| Mar 31, 2025 | 41.12 Mn |
| Dec 31, 2024 | 84.35 Mn |
| Dec 31, 2024 | 84.35 Mn |
| Sep 30, 2024 | 63.89 Mn |
| Sep 30, 2024 | 63.89 Mn |
| Jun 30, 2024 | 75.50 Mn |
| Jun 30, 2024 | 75.50 Mn |
| Mar 31, 2024 | 80.99 Mn |
| Mar 31, 2024 | 80.99 Mn |
| Dec 31, 2023 | 83.12 Mn |
| Dec 31, 2023 | 83.12 Mn |